PIER members are invited to provide comments on the revision of Eudralex Volume 4 ANNEX 1, Manufacture of Sterile Medicinal Products. These comments will be provided to the EIPG who will collate the feedback received from member organisations and send to the European Commission and the EMA. The consultation document can be accessed via the link below. Please provide your feedback to email@example.com before 4th March 2018.
Annex 1 was first published in 1971, since then it has undergone a number of targeted updates but, until now it has not undergone a full review. This revision is intended to add clarity, introduce the principles of Quality Risk Management to allow for the inclusion of new technologies and innovative processes and to change the structure to a more logical flow. Key changes are:
- Introduction of new sections: scope, utilities, Environmental and process monitoring sections and glossary
- Introduction of QRM Principles
- Restructured to give more logical flow
- Added detail to a number of the previous sections to provide further clarity.